2-Hydroxyestrone

2-hydroxyestrone is a lipid of Sterol Lipids (ST) class. 2-hydroxyestrone is associated with abnormalities such as Consumption-archaic term for TB and Estrogenic effect. The involved functions are known as Excretory function, Estrogen Metabolic Process, Urinary concentration, Biochemical Pathway and Cell Proliferation. 2-hydroxyestrone often locates in Mammary Gland Parenchyma. The associated genes with 2-Hydroxyestrone are CYP17A1 gene, CYP1A2 gene, SHBG gene and Alleles. The related lipids are 16-ketoestradiol and 4-methoxyestradiol.

Cross Reference

Introduction

To understand associated biological information of 2-Hydroxyestrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2-Hydroxyestrone?

2-Hydroxyestrone is suspected in Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2-Hydroxyestrone

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Total 1

PubChem Associated disorders and diseases

What pathways are associated with 2-Hydroxyestrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2-Hydroxyestrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2-Hydroxyestrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2-Hydroxyestrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2-Hydroxyestrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 2-Hydroxyestrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2-Hydroxyestrone

Download all related citations
Per page 10 20 50 100 | Total 245
Authors Title Published Journal PubMed Link
Dunlap TL et al. Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism. 2017 Chem. Res. Toxicol. pmid:28985473
Gao WL et al. Measurement of serum estrogen and estrogen metabolites in pre- and postmenopausal women with osteoarthritis using high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. 2015 Braz. J. Med. Biol. Res. pmid:25410577
Dikshit A et al. Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner. 2015 Br. J. Nutr. pmid:25850566
Gheldiu AM et al. Oxidative Metabolism of Estrone Modified by Genistein and Bisphenol A in Rat Liver Microsomes. 2015 Biomed. Environ. Sci. pmid:26695363
Telang N et al. Comparative efficacy of extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cells. 2014 Nutr Cancer pmid:24377707
Godínez Martínez EY et al. [Determination of 2-hydroxyestrone /16α-hydroxyestrone ratio in urine of Mexican women as a risk indicator for breast cancer and its relationship with other risk factors]. 2014 Nutr Hosp pmid:25617571
Arslan AA et al. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women. 2014 Cancer Epidemiol. Biomarkers Prev. pmid:24769889
Bazzan AJ et al. Multi-nutrient supplement improves hormone ratio associated with cancer risk. 2013 J Transl Med pmid:24103703
Morimoto Y et al. Urinary estrogen metabolites during a randomized soy trial. 2012 Nutr Cancer pmid:22293063
Maskarinec G et al. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. 2012 Cancer Epidemiol pmid:22537763
Maskarinec G et al. Urinary estrogen metabolites in two soy trials with premenopausal women. 2012 Eur J Clin Nutr pmid:22713773
Minorics R et al. Antiproliferative effect of normal and 13-epi-D-homoestrone and their 3-methyl ethers on human reproductive cancer cell lines. 2012 J. Steroid Biochem. Mol. Biol. pmid:22609630
Austin ED et al. BMPR2 expression is suppressed by signaling through the estrogen receptor. 2012 Biol Sex Differ pmid:22348410
Matthews CE et al. Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. 2012 J. Clin. Endocrinol. Metab. pmid:22855335
Sakuma K and Yamaguchi A Sarcopenia and age-related endocrine function. 2012 Int J Endocrinol pmid:22690213
Telang NT et al. Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor-positive clinical breast cancer. 2012 Mol Med Rep pmid:21971582
Bradlow HL et al. Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer. 2011 Jul-Aug In Vivo pmid:21709000
Zeleniuch-Jacquotte A et al. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer. 2011 Br. J. Cancer pmid:21952628
Tam A et al. The role of female hormones on lung function in chronic lung diseases. 2011 BMC Womens Health pmid:21639909
Obi N et al. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? 2011 Int J Womens Health pmid:21339936
Davies NJ et al. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. 2011 Br. J. Cancer pmid:22048034
Cleary MP and Grossmann ME The manner in which calories are restricted impacts mammary tumor cancer prevention. 2011 J Carcinog pmid:22013391
Fu L and Xu H A preliminary study of the effectiveness of chinese therapeutic food on regulating female reproductive hormones. 2011 Integr Med Insights pmid:21614163
Yu X et al. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. 2011 BMC Cancer pmid:21406107
Moon YJ et al. Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cells. 2011 Evid Based Complement Alternat Med pmid:20953429
Choi MH et al. Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma. 2011 BMC Cancer pmid:21824401
Pavan B et al. Estrogen metabolites in the release of inflammatory mediators from human amnion-derived cells. 2011 Life Sci. pmid:21277863
Gao W et al. Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis. 2010 J. Endocrinol. Invest. pmid:20339312
Laidlaw M et al. Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial. 2010 Breast Cancer (Auckl) pmid:21234288
Fleming JM et al. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. 2010 BMC Med pmid:20492690
Solís-Ortiz S et al. Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study. 2010 Behav Brain Funct pmid:21029471
Butler LM et al. Active, but not passive cigarette smoking was inversely associated with mammographic density. 2010 Cancer Causes Control pmid:19915951
Faupel-Badger JM et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. 2010 Cancer Epidemiol. Biomarkers Prev. pmid:20056650
Taioli E et al. Comparison of estrogens and estrogen metabolites in human breast tissue and urine. 2010 Reprod. Biol. Endocrinol. pmid:20678202
Sturgeon SR et al. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women. 2010 Nutr Cancer pmid:20099191
Wacker M et al. Ethnicity, body size, and estrogen levels in postmenopausal Hispanic and non-Hispanic white women. 2009 J Womens Health (Larchmt) pmid:19361315
Im A et al. Urinary estrogen metabolites in women at high risk for breast cancer. 2009 Carcinogenesis pmid:19502596
Barba M et al. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis. 2009 J. Exp. Clin. Cancer Res. pmid:19814782
Roman-Blas JA et al. Osteoarthritis associated with estrogen deficiency. 2009 Arthritis Res. Ther. pmid:19804619
Arslan AA et al. Circulating estrogen metabolites and risk for breast cancer in premenopausal women. 2009 Cancer Epidemiol. Biomarkers Prev. pmid:19661086
Crandall CJ et al. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. 2009 Breast Cancer Res. pmid:19630952
Li G et al. Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism. 2009 Nutr Cancer pmid:19373615
Capellino S et al. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. 2008 Sep-Oct Clin. Exp. Rheumatol. pmid:19032826
Sowers MR et al. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis". 2008 Arch. Intern. Med. pmid:18955645
Mense SM et al. Phytoestrogens and breast cancer prevention: possible mechanisms of action. 2008 Environ. Health Perspect. pmid:18414622
Chiesa IJ et al. Contribution of alpha2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells. 2008 J. Steroid Biochem. Mol. Biol. pmid:18486470
Aubertin-Leheudre M et al. Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. 2008 J. Steroid Biochem. Mol. Biol. pmid:18761407
Orgéas CC et al. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. 2008 Breast Cancer Res. pmid:19087323
Scott LM et al. Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis). 2008 Cancer Epidemiol. Biomarkers Prev. pmid:18843000
Jernström H et al. Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer. 2008 Br. J. Cancer pmid:18813311
BÃ¥geman E et al. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. 2008 Cancer Epidemiol. Biomarkers Prev. pmid:18398030
Dyrstad SW and Rao KA Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset. 2008 Clin Med Oncol pmid:21892322
Sowers M et al. Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress. 2008 Clin. Endocrinol. (Oxf) pmid:17980014
Falk RT et al. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. 2008 Cancer Epidemiol. Biomarkers Prev. pmid:19064556
Atkinson C et al. Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. 2008 Cancer Causes Control pmid:18478336
Cohen LA et al. Soy isoflavone intake and estrogen excretion patterns in young women: effect of probiotic administration. 2007 May-Jun In Vivo pmid:17591361
Hsu IP et al. The effects of soygerm extracts on blood lipoproteins, antioxidative capacity and urinary estrogen metabolites in postmenopausal women on hormone therapy. 2007 Int J Gynaecol Obstet pmid:17467711
Grady JJ Analysis of change. 2007 Methods Mol. Biol. pmid:18450054
Wood CE et al. Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. 2007 Carcinogenesis pmid:17032659
Dutta P et al. Development of a nanomechanical biosensor for analysis of endocrine disrupting chemicals. 2007 Lab Chip pmid:17713618
Greenlee H et al. A pilot and feasibility study on the effects of naturopathic botanical and dietary interventions on sex steroid hormone metabolism in premenopausal women. 2007 Cancer Epidemiol. Biomarkers Prev. pmid:17684134
Campbell KL et al. Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. 2007 Cancer Epidemiol. Biomarkers Prev. pmid:17416764
McCann SE et al. Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype. 2007 Cancer Epidemiol. Biomarkers Prev. pmid:17301257
Napoli N et al. Estrogen metabolism modulates bone density in men. 2007 Calcif. Tissue Int. pmid:17406768
Wentz MJ et al. Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats. 2007 Reproduction pmid:18042640
Lippert TH et al. Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol. 2007 J. Steroid Biochem. Mol. Biol. pmid:17081745
Naik R et al. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. 2006 Mar-Apr Int. J. Gynecol. Cancer pmid:16681761
Kristensen VN et al. Multilocus analysis of SNP and metabolic data within a given pathway. 2006 BMC Genomics pmid:16412218
Sowers MR et al. Estradiol and its metabolites and their association with knee osteoarthritis. 2006 Arthritis Rheum. pmid:16871545
Kabat GC et al. Estrogen metabolism and breast cancer. 2006 Epidemiology pmid:16357599
Masi CM et al. Estrogen metabolites and systolic blood pressure in a population-based sample of postmenopausal women. 2006 J. Clin. Endocrinol. Metab. pmid:16384842
Klug TL et al. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels. 2006 Mol. Genet. Metab. pmid:16978896
Sowers MR et al. Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women. 2006 J. Nutr. pmid:16702326
Zhu BT et al. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. 2006 Endocrinology pmid:16728493
Sowers MR et al. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. 2006 Am. J. Med. pmid:16949388
Wu WH et al. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women. 2006 Eur J Clin Nutr pmid:16278686
Cribb AE et al. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. 2006 Cancer Epidemiol. Biomarkers Prev. pmid:16537715
Teas J et al. Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina. 2005 Cancer Detect. Prev. pmid:16289388
Campbell KL et al. Associations between aerobic fitness and estrogen metabolites in premenopausal women. 2005 Med Sci Sports Exerc pmid:15809556
Paracchini V et al. A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. 2005 Clin. Chem. Lab. Med. pmid:16207128
Verla-Tebit E et al. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study. 2005 Breast Cancer Res. pmid:15987450
Schmidt M et al. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. 2005 Arthritis Res. Ther. pmid:16207335
Frankenfeld CL et al. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. 2004 J. Steroid Biochem. Mol. Biol. pmid:15145450
Basu NK et al. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. 2004 J. Biol. Chem. pmid:15117964
Brooks JD et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. 2004 Am. J. Clin. Nutr. pmid:14749240
Xu X et al. Measuring seven endogenous ketolic estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. 2004 Anal. Chem. pmid:15456304
Limer JL and Speirs V Phyto-oestrogens and breast cancer chemoprevention. 2004 Breast Cancer Res. pmid:15084232
Donaldson MS Nutrition and cancer: a review of the evidence for an anti-cancer diet. 2004 Nutr J pmid:15496224
Hawkins MB and Thomas P The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain. 2004 Endocrinology pmid:15001543
Hong CC et al. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. 2004 Breast Cancer Res. pmid:15217502
Atkinson C et al. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:15159321
Tworoger SS et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:14744739
Dalessandri KM et al. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. 2004 Nutr Cancer pmid:15623462
Hong CC et al. Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. 2004 Breast Cancer Res. pmid:15217501
Jernström H et al. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. 2003 Carcinogenesis pmid:12771045
Alvarez-Vasquez RB et al. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer. 2003 Horm. Metab. Res. pmid:12920658
Mueck AO et al. [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites]. 2003 Zentralbl Gynakol pmid:14634875
Fowke JH et al. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. 2003 Steroids pmid:12475724
Atkinson C et al. Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women. 2003 J. Steroid Biochem. Mol. Biol. pmid:12943746
Lee AJ et al. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. 2003 Endocrinology pmid:12865317